|
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid |
|
CHEBI:140273 |
|
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid |
|
A dihydroxydocosapentaenoic acid (DiHDPE) that is (8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid carrying two hydroxy substituents at positions 7 and 17. An intermediate of specialized proresolving mediators |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H34O4/c1-2-3-10-15-20(23)16-11-7-5-4-6-8-12-17-21(24)18-13-9-14-19-22(25)26/h3,5-8,10-12,16-17,20-21,23-24H,2,4,9,13-15,18-19H2,1H3,(H,25,26)/b7-5?,8-6?,10-3-,16-11+,17-12- |
JUBMLVBCKBUAQW-RULBWSPQSA-N |
C(=CCC=C/C=C/C(C/C=C\CC)O)/C=C\C(CCCCCC(O)=O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via DiHDPE )
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
|
|
View more via ChEBI Ontology
Outgoing
|
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid
(CHEBI:140273)
has role
human xenobiotic metabolite
(CHEBI:76967)
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid
(CHEBI:140273)
has role
specialised pro-resolving mediator
(CHEBI:140399)
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid
(CHEBI:140273)
is a
DiHDPE
(CHEBI:72656)
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid
(CHEBI:140273)
is conjugate acid of
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate
(CHEBI:140419)
|
|
Incoming
|
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate
(CHEBI:140419)
is conjugate base of
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid
(CHEBI:140273)
|
(8Z,15E,19Z)-7,17-dihydroxydocosa-8,10,13,15,19-pentaenoic acid
|
7,17-dihydroxy-(8Z,10,13,15E,19Z)-docosapentaenoic acid
|
ChEBI
|
7,17-dihydroxy-ω3-docosapentaenoic acid
|
ChEBI
|
7,17-dihydroxy-omega3-docosapentaenoic acid
|
ChEBI
|
resolvin D5n-3 DPA
|
ChEBI
|
RvD5n-3 DPA
|
SUBMITTER
|
23736886
|
PubMed citation
|
Europe PMC
|
28408222
|
PubMed citation
|
Europe PMC
|
|